Strs Ohio Sells 265,120 Shares of Global Medical REIT Inc. $GMRE

Strs Ohio trimmed its stake in Global Medical REIT Inc. (NYSE:GMRE) by 62.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 161,080 shares of the company’s stock after selling 265,120 shares during the period. Strs Ohio owned approximately 1.20% of Global Medical REIT worth $5,430,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of the stock. Gabelli Funds LLC bought a new stake in Global Medical REIT during the second quarter worth about $2,829,000. Invesco Ltd. increased its holdings in shares of Global Medical REIT by 30.5% in the second quarter. Invesco Ltd. now owns 1,518,668 shares of the company’s stock worth $10,524,000 after buying an additional 355,355 shares during the period. Marshall Wace LLP lifted its stake in shares of Global Medical REIT by 2,208.2% in the 2nd quarter. Marshall Wace LLP now owns 291,708 shares of the company’s stock valued at $2,022,000 after acquiring an additional 279,070 shares during the last quarter. LDR Capital Management LLC purchased a new stake in Global Medical REIT during the 2nd quarter valued at about $1,213,000. Finally, Redmond Asset Management LLC boosted its holdings in Global Medical REIT by 63.0% during the 2nd quarter. Redmond Asset Management LLC now owns 426,622 shares of the company’s stock valued at $2,956,000 after acquiring an additional 164,909 shares during the period. 57.52% of the stock is currently owned by institutional investors.

Global Medical REIT Price Performance

Shares of NYSE:GMRE opened at $35.21 on Tuesday. The business has a fifty day moving average price of $34.13 and a 200-day moving average price of $34.18. The company has a debt-to-equity ratio of 1.65, a current ratio of 0.52 and a quick ratio of 0.52. The company has a market capitalization of $472.17 million, a PE ratio of -140.84 and a beta of 1.18. Global Medical REIT Inc. has a 1-year low of $29.05 and a 1-year high of $45.75.

Global Medical REIT (NYSE:GMRE) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $1.12 EPS for the quarter, beating the consensus estimate of $1.05 by $0.07. The company had revenue of $37.23 million for the quarter, compared to the consensus estimate of $38.15 million. Global Medical REIT had a net margin of 0.79% and a return on equity of 0.25%. Global Medical REIT has set its FY 2025 guidance at 4.500-4.600 EPS. As a group, equities analysts expect that Global Medical REIT Inc. will post 0.81 EPS for the current fiscal year.

Global Medical REIT Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 9th. Investors of record on Friday, December 19th were given a $0.75 dividend. The ex-dividend date of this dividend was Friday, December 19th. This represents a $3.00 annualized dividend and a yield of 8.5%. Global Medical REIT’s dividend payout ratio is -1,200.00%.

Insider Buying and Selling

In other Global Medical REIT news, CEO Mark Okey Decker, Jr. bought 10,000 shares of the firm’s stock in a transaction on Friday, November 14th. The stock was acquired at an average price of $32.58 per share, with a total value of $325,800.00. Following the transaction, the chief executive officer owned 44,774 shares in the company, valued at $1,458,736.92. This represents a 28.76% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 8.50% of the company’s stock.

Analyst Ratings Changes

GMRE has been the subject of several recent research reports. Wall Street Zen downgraded Global Medical REIT from a “hold” rating to a “sell” rating in a research report on Saturday, November 8th. Robert W. Baird cut their target price on Global Medical REIT from $45.00 to $41.00 and set a “neutral” rating on the stock in a research note on Tuesday, November 11th. Weiss Ratings upgraded shares of Global Medical REIT from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, January 21st. JMP Securities set a $40.00 price objective on shares of Global Medical REIT and gave the company a “market outperform” rating in a research report on Monday, October 13th. Finally, Citizens Jmp raised shares of Global Medical REIT from a “market perform” rating to an “outperform” rating and set a $40.00 target price for the company in a research report on Monday, October 13th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, Global Medical REIT presently has an average rating of “Moderate Buy” and an average price target of $41.50.

Global Medical REIT Profile

Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.